日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 mice

作者更正:基于腺相关病毒(AAV)的RNAi靶向ataxin-2可改善TDP-43小鼠的存活率和病理状况。

Amado, Defne A; Robbins, Ashley B; Whiteman, Katherine R; Smith, Alicia R; Chillon, Guillem; Chen, Yonghong; Fuller, Joshua A; Patty, Nicholas A; Izda, Aleksandar; Cheng, Congsheng; Nelson, Shareen; Dichter, Abigail I; Mazzoni, Esteban O; Monteys, Alex Mas; Davidson, Beverly L

AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 mice.

基于 AAV 的 RNAi 递送靶向 ataxin-2 可改善 TDP-43 小鼠的生存率和病理状况

Amado Defne A, Robbins Ashley B, Whiteman Katherine R, Smith Alicia R, Chillon Guillem, Chen Yonghong, Fuller Joshua A, Patty Nicholas A, Izda Aleksandar, Cheng Congsheng, Nelson Shareen, Dichter Abigail I, Mazzoni Esteban O, Monteys Alex Mas, Davidson Beverly L

AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALS

基于腺相关病毒载体(AAV)的RNAi递送靶向Ataxin-2可改善快速进展型和缓慢进展型散发性肌萎缩侧索硬化症(ALS)小鼠模型的生存率、力量和病理状况。

Amado, Defne A; Robbins, Ashley B; Smith, Alicia R; Whiteman, Katherine R; Chillon Bosch, Guillem; Chen, Yonghong; Fuller, Joshua A; Izda, Aleksandar; Nelson, Shareen; Dichter, Abigail I; Monteys, Alex Mas; Davidson, Beverly L

Temporal Phenotypic Changes in Huntington's Disease Models for Preclinical Studies

亨廷顿病模型中表型的时间变化及其在临床前研究中的应用

St-Cyr, Sophie; Smith, Alicia R; Davidson, Beverly L